Thailand Food and Drug Administration Meeting on 10 November 2021

Thailand Food and Drug Administration Meeting on 10 November 2021

On 10th November, Thailand Food and Drug Administration hosted a Hybrid meeting with members of EABC Healthcare & Pharmaceuticals Working Group to discuss and exchange about Biologic Median Price Guideline.

EABC recognized the patient safety and patient treatment outcome as high priorities that we would like to support and collaborate with multi-stakeholders in bringing innovations and good quality medicines for the access of Thai patients as medical needs and Biological product is one among the innovative medicines that can benefit patient treatments in various therapeutic areas.

Earlier in June 2021, EABC also submitted EABC Position paper on Biologic Median Price guideline based on international practices and researches to the FDA, in which we presented to the FDA in this meeting.